No Data
No Data
Optimistic Growth Prospects for Supernus Pharmaceuticals Driven by Qelbree's Market Potential
Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Surpass Estimates
Express News | Supernus Pharmaceuticals Affirms FY2025 Sales Guidance of $600.00M-$630.00M Vs $624.69M Est
Supernus Pharmaceuticals | 10-Q: Quarterly report
Earnings Flash (SUPN) Supernus Pharmaceuticals Reports Q1 Revenue $149.8M, Vs. FactSet Est of $147.9M
Supernus Pharmaceuticals | 8-K: Supernus Announces First Quarter 2025 Financial Results